CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...